Prescribing patterns and persistence of biological therapies for psoriasis management: a retrospective cohort study from Saudi Arabia
This study shows changing psoriasis treatment patterns with new therapies. Risankizumab demonstrated high long-term persistence, while etanercept and ustekinumab showed declining persistence, suggesting evolving treatment considerations.
Authors
- Tuqa Morad Alkaff (ORCID: https://orcid.org/0000-0001-6921-1103)
- Mukhtar Alomar (ORCID: https://orcid.org/0000-0001-7798-6881)
- Ahmad Alamer (ORCID: https://orcid.org/0000-0002-2091-1376)
- Ziyad S. Almalki (ORCID: https://orcid.org/0000-0003-1618-4142)
- Sarah Almakki
- Abdullah K. Alahmari (ORCID: https://orcid.org/0000-0002-1047-6913)
- Saad A. Aldosari (ORCID: https://orcid.org/0000-0001-7097-1257)
- Wejdan Alyazidi
- Mohammad Fazel (ORCID: https://orcid.org/0000-0002-3904-9835)
- Fatimah Mobarki
Institutions
- University of Arizona (US)
- Prince Sattam Bin Abdulaziz University (SA)
- Eastern Health (AU)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1080/09546634.2024.2386973
- Citations
- 1
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.24